AQR Capital Management’s Voyager Therapeutics VYGR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $881K | Sell |
283,206
-212,054
| -43% | -$659K | ﹤0.01% | 2288 |
|
|
2025
Q1 | $1.67M | Buy |
495,260
+317,927
| +179% | +$1.07M | ﹤0.01% | 1709 |
|
|
2024
Q4 | $1.01M | Sell |
177,333
-71,290
| -29% | -$404K | ﹤0.01% | 1884 |
|
|
2024
Q3 | $1.45M | Sell |
248,623
-253,752
| -51% | -$1.48M | ﹤0.01% | 1655 |
|
|
2024
Q2 | $3.97M | Sell |
502,375
-291,259
| -37% | -$2.3M | 0.01% | 1121 |
|
|
2024
Q1 | $7.39M | Buy |
793,634
+154,347
| +24% | +$1.44M | 0.01% | 828 |
|
|
2023
Q4 | $5.4M | Buy |
639,287
+440,465
| +222% | +$3.72M | 0.01% | 915 |
|
|
2023
Q3 | $1.54M | Buy |
+198,822
| New | +$1.54M | ﹤0.01% | 1435 |
|
|
2021
Q3 | – | Sell |
-166,330
| Closed | -$687K | – | 2339 |
|
|
2021
Q2 | $687K | Sell |
166,330
-196,108
| -54% | -$810K | ﹤0.01% | 1754 |
|
|
2021
Q1 | $1.71M | Buy |
362,438
+195,083
| +117% | +$919K | ﹤0.01% | 1291 |
|
|
2020
Q4 | $1.2M | Buy |
167,355
+141,435
| +546% | +$1.01M | ﹤0.01% | 1426 |
|
|
2020
Q3 | $277K | Sell |
25,920
-25,644
| -50% | -$274K | ﹤0.01% | 1947 |
|
|
2020
Q2 | $651K | Sell |
51,564
-6,966
| -12% | -$87.9K | ﹤0.01% | 1650 |
|
|
2020
Q1 | $536K | Sell |
58,530
-11,926
| -17% | -$109K | ﹤0.01% | 1555 |
|
|
2019
Q4 | $983K | Sell |
70,456
-7,449
| -10% | -$104K | ﹤0.01% | 1521 |
|
|
2019
Q3 | $1.34M | Buy |
77,905
+57,299
| +278% | +$986K | ﹤0.01% | 1423 |
|
|
2019
Q2 | $561K | Sell |
20,606
-4,059
| -16% | -$111K | ﹤0.01% | 1691 |
|
|
2019
Q1 | $472K | Sell |
24,665
-24,924
| -50% | -$477K | ﹤0.01% | 1822 |
|
|
2018
Q4 | $466K | Buy |
49,589
+30,608
| +161% | +$288K | ﹤0.01% | 1811 |
|
|
2018
Q3 | $359K | Sell |
18,981
-4,346
| -19% | -$82.2K | ﹤0.01% | 2057 |
|
|
2018
Q2 | $456K | Buy |
+23,327
| New | +$456K | ﹤0.01% | 2006 |
|